Japan Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Mobile Game Development Course Learn how to create awesome HTML5 games that run on iPhone, iPad, Android and Desktop! Sign up today for this $99 online course. From our sponsors

Japan Pharmaceuticals and Healthcare Report Q4 2013 Sep 4th 2013, 00:00, by rnrmahesh BMI View: An ageing population, coupled with the country’s high expenditure on healthcare, makes Japan a very attractive market for drugmakers. We highlight that given Prime Minister Shinzo Abe’s aim to revitalise the economy there will potentially be stronger support for research and development, maintaining the country’s leadership in the Asia Pacific region. While the ageing population demands more pharmaceutical and medical services, the growth potential of the pharmaceutical market will eventually be limited by its shrinking population. Headline Expenditure Projections ? Pharmaceuticals: JPY10,338.7bn (US$129.5bn) in 2012 to JPY10,795.2bn (US$118.6bn) in 2013; +4.4% in local currency terms and -8.4% in … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=113323. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/japan-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions